003850.KS KSC
Boryung Corporation
1W: +1.7%
1M: -7.1%
3M: -0.8%
YTD: -11.7%
1Y: +0.1%
3Y: +6.1%
5Y: -55.9%
₩8,420.00 ($6.27)
-40.00 (-0.47%)
Weekly Expected Move ±5.5%
₩7500
₩7960
₩8420
₩8880
₩9340
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩711.3B ($529.8M)
52W Range7410-10800
Volume35,743
Avg Volume120,972
Beta0.29
Dividend₩160.00
Analyst Ratings
No analyst coverage
Company Info
CEOJeong-Gyun Kim
Employees1,645
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1988-10-24
Websiteboryung.co.kr
Boryeong Building
Seoul, SL 03127
KR
Seoul, SL 03127
KR
82 2 708 8000
About Boryung Corporation
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found